Background
COVID-19 is a pandemic disease that has paralyzed social life and the economy around the world since the end of 2019, and which has so far killed nearly 600,000 people. The rapidity of its spread and the lack of detailed research on the course and methods of transmission significantly impede both its eradication and prevention.
Scope and approach
Due to the high transmission rate and fatality resulting from COVID-19 disease, the paper focuses on analyzing the current state of knowledge about SARS-CoV-2 as well as its potential connection with food as a source of pathogen and infection.
Key findings and conclusions
There is currently no evidence (scientific publications, WHO, EFSA etc.) that COVID-19 disease can spread directly through food and the human digestive system. However, according to the hypothesis regarding the primary transmission of the virus, the source of which was food of animal origin (meat of wild animals), as well as the fact that food is a basic necessity for humans, it is worth emphasizing that food can, if not directly, be a carrier of the virus. Particular attention should be paid to this indirect pathway when considering the potential for the spread of an epidemic and the development of prevention principles.
This review provides insight into consumer attitudes toward functional food (FF), with the purpose of better understanding the needs and behavior regarding this kind of product. A total of 47 articles were selected for this paper. The available studies from last 20 years differ according to the focus (awareness, attitudes, motivations, willingness, acceptance by consumers) and methodologies used. Several factors, including socio-demographic, cognitive and attitudinal ones, seem to be serve as the basis for the acceptance of functional products. The research papers showed that nutritional knowledge is the most important of these. Older people are more interested in functional products than younger consumers, because of their stronger belief in the health benefits of FF. Moreover, women are more open to compromise between taste and health properties. Claims concerning the disease preventative properties of FF are the most attractive for consumers. This review focuses also on future perspectives for the functional food market. Adequate knowledge and evidence-based communication seem to be the most promising ways to increase consumers’ interest in these kinds of products.
Powders of tubers from Jerusalem artichoke (Helianthus tuberosus, L.), cultivar Gigant, of different harvesting times (autumn and spring) were applied in bakery products, particularly in wheat/rye bread. The quality of this bread was compared to bread with cereal flours substituted with commercial products as Raftilin ST and Raftilose P95. Compared to standard and substituted bread, Jerusalem artichoke bread shows a high quality in organoleptic evaluation (grade I with 36.5 and 37.5 scores). In utilised Jerusalem artichoke powders (JAPs) the amount of fructan (inulin) hydrolysis to fructose during the baking process depends on its initial degree of polymerisation (dp). With JAP of autumn harvest (fructan: dpn = 9.9, dpw = 21.8) less fructose (24.6%) is formed than with those of spring harvest (fructan: dpn = 4.9, dpw = 7.1) (40.7%). Compared to this bread, substitution with commercial products Raftilin ST (inulin: dpn = 8.4, dpw = 17.4) and Raftilose P95 (fructo-oligosaccharides: dpn = 2.7, dpw = 3.0) yields 11.9% and 45.8% of fructose upon total hydrolysis, respectively. The loss of fructan content by the bakery process is 38% in bread with JAP of autumn and 43% in bread with JAP of spring harvest; Raftilin ST- and Raftilose P95-bread come up with loss of fructan content of 35% and 47%, respectively.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.